J. L. Barascut
University of Montpellier
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. L. Barascut.
Nucleosides, Nucleotides & Nucleic Acids | 2001
H. B. Lazrek; M. Taourirte; T. Oulih; J. L. Barascut; Jean-Louis Imbach; Christophe Pannecouque; M. Witrouw; E. De Clercq
The synthesis of 1,2,3-triazole acyclonucleosides 7a-h via 1,3-dipolar cycloaddition of N-9/N-1-propargylpurine/pyrimidine 2a-h with azido-pseudo-sugar 4 is described and none of them had anti-HIV activity.
Tetrahedron | 1998
H. B. Lazrek; A. Rochdi; H. Khaider; J. L. Barascut; Jean-Louis Imbach; Jan Balzarini; Myriam Witvrouw; Christophe Pannecouque; E. De Clercq
Abstract (Z) and (E)-2-(purin-9-yl/ pyrimidin-1-yl)ethylen-1-ylphosphonic acid 10–18 were synthetized by Michael addition of heterocyclic base with the diethylethynylphosphonate and deprotection of the acyclic nucleoside phosphonate with bromotrimethylsilane.
Nucleosides, Nucleotides & Nucleic Acids | 1992
Laurent Bellon; J. L. Barascut; Jean-Louis Imbach
Abstract A synthetic pathway to reach easily the 4-thio-D-ribofuranose is described. Some corresponding pyrimidine α and β 4′-thioribonucleosides have been synthesized and evaluated as antiviral agents against various viruses.
Tetrahedron Letters | 1996
H.B. Lazrek; H. Khaïder; A. Rochdi; J. L. Barascut; Jean-Louis Imbach
Abstract New acyclic nucleoside phosphonic acids in the purine and pyrimidine series were prepared via one step by Michael addition. These compounds are the first reported acyclonucleosides enamines which incorporate the α, β-unsaturated phosphonic acid as a phosphate mimic.
Nucleosides, Nucleotides & Nucleic Acids | 2001
Omar Moukha-Chafiq; Mohamed Labd Taha; H. B. Lazrek; Christophe Pannecouque; Myriam Witvrouw; E. De Clercq; J. L. Barascut; Jean-Louis Imbach
The chemical synthesis of some 4-substituted 1-[1-(2-hydroxyethoxy)methyl-1,2,3-triazol-(4 and 5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines 12a,b, 13a,b and 14–23 as acyclic nucleosides is described. Treatment of (2-acetoxyethoxy)methylbromide with sodium azide afforded (2-acetoxyethoxy)methylazide 9. The heterocycles 6a,b were alkylated, separately, with propargyl bromide to obtain, regioselectively, 4-(methyl and benzyl)thio-1-(prop-2-ynyl)-1H-pyrazolo[3,4-d]pyrimidines 7a,b. These N1-alkylated products were condensed with compound 9 via a 1,3-dipolar cycloaddition reaction to obtain, after separation and deprotection, 1,4 and 1,5-regioisomers 12a,b and 13a,b. The deprotected acyclic nucleosides 12a and 13a served as precursors for the preparation of 4-amino (14 and 15), 4-methylamino (16 and 17), 4-benzylamino (18 and 19), 4-methoxy (20 and 21) and 4-hydroxy (22 and 23) analogues. Compounds 7a,b and all deprotected acyclic nucleosides were evaluated for their inhibitory effects against the replication of HIV-1(IIIB) and HIV-2(ROD) in MT-4 cells and for their anti-tumor activity. No marked activity was found. However, initial evaluation of 6a,b, 7a,b, 12a,b, 13a,b and 14–23 showed that compound 7b has marked activity against M. tuberculosis.
Nucleosides, Nucleotides & Nucleic Acids | 2003
M. Tourirte; T. Oulih; H. B. Lazrek; J. L. Barascut; Jean-Louis Imbach; Najim A. Al-Masoudi
Abstract The synthesis of new 3′-deoxy-3′-[4-(pyrimidin-1-yl)methyl-1,2,3-triazol-1-yl]thymidine 6a–f, from 3′-azido-3′-deoxy-5′-O-monomethoxytrityl-thymidine is described. The key step is the 1,3-dipolar cycloaddition between the azido group of the protected AZT 3 and N-1-propargylpyrimidine derivatives 2a–f. All new derivatives 6a–f were evaluated for their inhibitory effects against the replication of HIV-1 (IIIB), HIV-2 (ROD). No marked activity was found.
Nucleosides, Nucleotides & Nucleic Acids | 1997
H. B. Lazrek; M. Taourirte; T. Oulih; M. Lebtoumi; J. L. Barascut; Jean-Louis Imbach
Abstract 1,3-dipolar cycloaddition of. N-9/N-1-propargylpurine/pyrimidine to the corresponding azido-compounds 9–10 produces acyclonucleoside analogues 13a-h, 14a-h in which the 4-methyl-1,2,3-triazole is used as spacer arm.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Hassan B. Lazrek; M. Taourirte; T. Oulih; Y. Kabbaj; J. L. Barascut; Jean-Louis Imbach; Najim A. Al-Masoudi; Wolfgang Pfleiderer
Abstract Synthesis of new 3′-deoxy-3′ and 5′-deoxy-5′-[(4-(purin-9-yl/pyrimidin-1-yl)methyl-1,2,3-Triazol-1-yl]thymidine 8a-g 10a-g from 3′-azido-3′-deoxy-5′-O-monomethoxytrityl-thymidine and 5′-azido-5′deoxythymidine respectively are described. The key step is the 1,3-dipolar cycloaddition between the azido group and N-9/N-1-propargylpurine/pyrimidine derivatives.
Nucleosides, Nucleotides & Nucleic Acids | 1995
C. Leydier; Laurent Bellon; J. L. Barascut; Jean-Louis Imbach
Abstract The syntheses and the study of nuclease resistance and hydrogen bonding of modified oligoribonucleotides, i.e. 4′-thio-β-D-oligoribonucleotides (4′-S-RNA), are reported.
Nucleosides, Nucleotides & Nucleic Acids | 2001
N. Redwane; H. B. Lazrek; J. L. Barascut; Jean-Louis Imbach; Jan Balzarini; Myriam Witvrouw; E. De Clercq
Synthesis of Z and E ethenyl acyclonucleosides (6a-e and 7a-e) via Michael addition of nucleobases with the diethyl acetylenedicarboxylate is described. The structures of compounds have been confirmed by spectral data. New compounds were found to be inactive against DNA and RNA viruses.